Cargando…
Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children
Although Mycoplasma pneumoniae pneumonia (MPP) has been generally susceptible to macrolides, the emergence of macrolide-resistant MPP (MRMP) has made its treatment challenging. MRMP rapidly spread after the 2000s, especially in East Asia. MRMP is more common in children and adolescents than in adult...
Autor principal: | Yang, Hyeon-Jong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584239/ https://www.ncbi.nlm.nih.gov/pubmed/30999732 http://dx.doi.org/10.3345/kjp.2018.07367 |
Ejemplares similares
-
Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children
por: Yang, Hyeon-Jong, et al.
Publicado: (2017) -
Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia
por: Yang, Eun-Ae, et al.
Publicado: (2017) -
Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan
por: Wu, Han-Meng, et al.
Publicado: (2012) -
Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids
por: Han, Hye Young, et al.
Publicado: (2021) -
Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children
por: Lee, Eun, et al.
Publicado: (2017)